European Leukemia Trial Registry
Trial: MDS Thymoglobulin

More Details
Title Thymoglobulin in MDS
Scientific Title A Phase II Study of Efficacy of Rabbit Antithymoglobulin (rATG) in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndrome
Short Title MDS Thymoglobulin
Trialgroup Nordic MDS
Type of Trial multicentric
Disease Myelodysplastic Syndrome(MDS) Low risk and intermedia I
Age <= 60 years
Status Closed
Start of Recruitment 01.02.2008
Leader Ganser, Prof. Dr. med., Arnold

principal investigator
Ganser, Prof. Dr. med., Arnold

Centre of Trial Medizinische Hochschule Hannover (MHH)
Shortprotocol Shortprotocol
created 14.02.2008 Roswitha Kotthoff
changed 13.11.2014 Alexandra Lucaciu
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |